MAPT and Alzheimer disease: There is numerous evidence that the gut microbiota plays a role in the neuropathology of AD and has an impact on a number of processes linked to its etiology, including neuroinflammation, neurotransmitter dysregulation, Aβ abnormality, oxidative stress, and tau phosphorylation [97].